Table 3.
B | SE | Wald | OR | P value | 95% confidence interval | ||
---|---|---|---|---|---|---|---|
Lower limit | Upper limit | ||||||
Threshold | 0.705 | 1.934 | 0.133 | 0.716 | |||
4.465 | 1.934 | 5.327 | 0.021 | ||||
Baseline CD4 cell count (cells/μl) | |||||||
< 100 | 3.219 | 0.224 | 206.140 | 24.994 | < 0.001 | 16.114 | 38.807 |
101 ~ 199 | 2.506 | 0.186 | 181.218 | 12.252 | < 0.001 | 8.506 | 17.649 |
200 ~ 349 | 1.244 | 0.161 | 59.899 | 3.469 | < 0.001 | 2.531 | 4.753 |
≥ 350 | 0a | ||||||
Baseline CD4/CD8 ratio | |||||||
< 0.2 | 0.845 | 0.186 | 20.639 | 2.327 | < 0.001 | 1.615 | 3.349 |
0.2 ~ 0.5 | 0.374 | 0.168 | 4.929 | 1.453 | 0.026 | 1.044 | 2.019 |
> 0.5 | 0a | ||||||
HAART regimen | |||||||
Including LPV/r | −0.573 | 0.286 | 4.012 | 0.563 | 0.045 | 0.176 | 0.988 |
NVP + 3TC + D4T | −0.128 | 0.207 | 0.381 | 0.879 | 0.537 | 0.586 | 1.320 |
EFV + 3TC + D4T | −0.261 | 0.306 | 0.723 | 0.770 | 0.395 | 0.422 | 1.404 |
3TC + EFV + AZT | 0.098 | 0.183 | 0.284 | 1.100 | 0.594 | 0.770 | 1.579 |
NVP + 3TC + AZT | 0.059 | 0.153 | 0.148 | 1.060 | 0.700 | 0.786 | 1.430 |
3TC + TDF + EFV | 0a | ||||||
HAART time (year) | |||||||
< 2 | 1.417 | 0.248 | 32.776 | 4.124 | < 0.001 | 2.539 | 6.697 |
2 ~ 4 | 0.852 | 0.227 | 14.132 | 2.344 | < 0.001 | 1.503 | 3.654 |
4 ~ 7 | 0.652 | 0.192 | 11.570 | 1.919 | 0.001 | 1.137 | 2.795 |
7 ~ 11 | 0a |
areference group